Decision-making Among Hepatitis C Virus-negative Transplant Candidates Offered Organs from Donors with HCV Infection

BACKGROUND. Historically, many organs from deceased donors with hepatitis C virus (HCV) were discarded. The advent of highly curative direct-acting antiviral (DAA) therapies motivated transplant centers to conduct trials of transplanting HCV-viremic organs (nucleic acid amplification test positive)...

Descripción completa

Detalles Bibliográficos
Autores principales: Saine, M. Elle, Schnellinger, Erin M., Liu, Michel, Diamond, Joshua M., Crespo, Maria M., Prenner, Stacey, Potluri, Vishnu, Bermudez, Christian, Mentch, Heather, Moore, Michaella, Besharatian, Behdad, Goldberg, David S., Barg, Frances K., Reese, Peter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Organ Donation and Procurement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298473/
https://www.ncbi.nlm.nih.gov/pubmed/35923812
http://dx.doi.org/10.1097/TXD.0000000000001341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298473/
https://www.ncbi.nlm.nih.gov/pubmed/35923812
http://dx.doi.org/10.1097/TXD.0000000000001341

Ejemplares similares